INS and type 1 diabetes mellitus: Current treatments still mainly rely on daily extraneous insulin regimens, which can negatively affect the quality of life for patients suffering from T1D and is difficult to manage proper glycemic control over an entire lifespan [[2], [3], [4], [5]].